U.S. Markets close in 2 hrs 36 mins

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
40.635-0.115 (-0.282%)
As of 1:24PM EDT. Market open.
People also watch
AZNNVSSNYLLYBMY
Full screen
Previous Close40.750
Open40.290
Bid40.610 x 1500
Ask40.620 x 1200
Day's Range40.290 - 40.660
52 Week Range37.200 - 45.580
Volume4,272,184
Avg. Volume2,775,892
Market Cap95.69B
Beta1.07
PE Ratio (TTM)45.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.95 (4.65%)
Ex-Dividend Date2017-05-10
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017
    Capital Cube48 minutes ago

    GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017

    Categories: Yahoo FinanceGet free summary analysis GlaxoSmithKline Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of GlaxoSmithKline Plc – Novartis AG Sponsored ADR and Innoviva, Inc. (NVS-US and INVA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 9,476.11 million, Net ... Read more (Read more...)

  • Morningstar6 hours ago

    Gilead's HCV and HIV Drugs Support Wide Moat

    We don't think the current price accounts for the company's pipeline.

  • Dividends a worry at drugmakers Astra, GSK after dramatic week
    Reuters7 hours ago

    Dividends a worry at drugmakers Astra, GSK after dramatic week

    Britain's two big drugmakers face very different challenges but they share a common problem: how to convince investors that their dividends are safe. With both stocks offering a dividend yield of more than 5 percent, AstraZeneca and GlaxoSmithKline provide islands of decent income in a sea of low returns. The chief executives of both companies faced a barrage of questions from analysts about future payouts and were forced to defend their dividend strategies at post-results meetings this week.